Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study

por Jin, Jia-Nan, Yue, Peng, Hao, Yue, Wu, Shi-Yan, Dong, Bai-Qiang, Wu, Qing, Song, Zheng-Bo, Chen, Ming
Publicado 2022

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib

por Zhu, You-cai, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Song, Zheng-bo, Du, Kai-qi, Chen, Gang, Lv, Tang-feng, Song, Yong
Publicado 2018

Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib

por Xu, Chun-wei, Wang, Wen-xian, Chen, Yan-ping, Chen, Yu, Liu, Wei, Zhong, Li-hua, Chen, Fang-fang, Zhuang, Wu, Song, Zheng-bo, Chen, Xiao-hui, Huang, Yun-jian, Guan, Yan-fang, Yi, Xin, Lv, Tang-feng, Zhu, Wei-feng, Lu, Jian-ping, Wang, Xiao-jiang, Shi, Yi, Lin, Xian-dong, Chen, Gang, Song, Yong
Publicado 2018